Updated:
June 07, 2021 12:57 IST
The trial on children has already started at AIIMS Patna to see if Bharat Biotech’s COVID-19 vaccine Covaxin is suitable for children
Share Article
AAA
Participants would be given the vaccine after their screening report comes. File
| Photo Credit:
K.K. Mustafah
The trial on children has already started at AIIMS Patna to see if Bharat Biotech’s COVID-19 vaccine Covaxin is suitable for children The screening of children for trial of Covaxin, India’s first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS in New Delhi on June 7.
The trial on children has already started at AIIMS Patna to see if the Bharat Biotech jab is suitable for children. Participants would be given the vaccine after their screening report comes.
India News: Congress leader Rahul Gandhi on Monday hit out at the government over the rise in petrol prices, and said the waves of tax collection epidemic are con
759
New Delhi, June 7
The screening of children for the trial of Covaxin, India s first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS here on Monday.
The trial on children has already started at AIIMS Patna to see if the Bharat Biotech jab is suitable for children.
Participants would be given the vaccine after their screening report comes.
The trial is to be conducted on 525 healthy volunteers. In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28. The screening of children for conducting trial of Covaxin has started. Participants would be given the vaccine after their screening reports come, Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS, said.
The screening of children for trial of Covaxin, India s first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS here on Monday. The trial on children has already started at AIIMS Patna to see if the Bharat Biotech jab is suitable for children. Participants would be given the vaccine after their screening report comes. The trial is to be conducted on 525 healthy volunteers. In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28. The screening of children for conducting trial of Covaxin has started. Participants would be given the vaccine after their screening reports come, Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS, said.
Read more about Data sharing going on with WHO to give recognition to Covaxin: Govt on Business Standard. Responding to a question on recognition of Covaxin by the WHO, NITI Aayog Member (Health) V K Paul said the government is pursuing it.